Cargando…
The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry
Two to three percent of the world's population is chronically infected with hepatitis C virus (HCV) and thus at risk of developing liver cancer. Although precise mechanisms regulating HCV entry into hepatic cells are still unknown, several cell surface proteins have been identified as entry fac...
Autores principales: | Rocha-Perugini, Vera, Montpellier, Claire, Delgrange, David, Wychowski, Czeslaw, Helle, François, Pillez, André, Drobecq, Hervé, Le Naour, François, Charrin, Stéphanie, Levy, Shoshana, Rubinstein, Eric, Dubuisson, Jean, Cocquerel, Laurence |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270906/ https://www.ncbi.nlm.nih.gov/pubmed/18382656 http://dx.doi.org/10.1371/journal.pone.0001866 |
Ejemplares similares
-
The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry
por: Rocha-Perugini, Vera, et al.
Publicado: (2009) -
WINT - an interpretive language for the ISR Argus 500 computer
por: Gorman, B M, et al.
Publicado: (1973) -
Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell Migration
por: Suwatthanarak, Thanawat, et al.
Publicado: (2023) -
CD81 and Hepatitis C Virus (HCV) Infection
por: Fénéant, Lucie, et al.
Publicado: (2014) -
Hepatitis C virus entry into the hepatocyte
por: Belouzard, Sandrine, et al.
Publicado: (2011)